Grey Wolf Animal Health Past Earnings Performance
Past criteria checks 1/6
Grey Wolf Animal Health has been growing earnings at an average annual rate of 81.5%, while the Pharmaceuticals industry saw earnings growing at 32.1% annually. Revenues have been growing at an average rate of 31.6% per year. Grey Wolf Animal Health's return on equity is 2.4%, and it has net margins of 2.4%.
Key information
81.5%
Earnings growth rate
74.3%
EPS growth rate
Pharmaceuticals Industry Growth | 23.1% |
Revenue growth rate | 31.6% |
Return on equity | 2.4% |
Net Margin | 2.4% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Revenue & Expenses Breakdown
How Grey Wolf Animal Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 25 | 1 | 10 | 0 |
30 Sep 23 | 25 | 7 | 10 | 0 |
30 Jun 23 | 24 | 5 | 10 | 0 |
31 Mar 23 | 24 | 4 | 11 | 0 |
31 Dec 22 | 23 | 3 | 11 | 0 |
30 Sep 22 | 22 | -3 | 10 | 0 |
30 Jun 22 | 19 | -3 | 9 | 0 |
31 Mar 22 | 16 | -2 | 7 | 0 |
31 Dec 21 | 13 | -1 | 6 | 0 |
31 Dec 20 | 8 | -1 | 4 | 0 |
Quality Earnings: WOLF has high quality earnings.
Growing Profit Margin: WOLF's current net profit margins (2.4%) are lower than last year (11.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if WOLF's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: WOLF's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: WOLF had negative earnings growth (-76%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (32.7%).
Return on Equity
High ROE: WOLF's Return on Equity (2.4%) is considered low.